Biomarkers – Webinars and Online Events

Attend this webinar to learn about:
- Discover opportunities that exist in clinical research testing for protein biomarkers (particularly in cardiovascular disease)
- Learn the advantages in performing protein quantification at higher flow rates
- Understand the considerations for implementing an LC-MS analysis for protein biomarker quantification in a clinical translational context

Multiplex assays combine several target analytes in a single reaction volume, allowing multiple biomarkers to be measured simultaneously.

The best fluids for mining disease biomarkers are closest to the site of pathology. For example, rather than serum or plasma, urine is a better fluid to in patients with urinary tract diseases, and stool may be a preferred material to examine in a subject with gastrointestinal disease.

No targeted therapies currently exist for this disease, and the only drug approved by the US Food and Drug Administration is effective in just one third of patients.

Returning for its third year, this online symposium will once again bring together leading scientists in the field as they highlight the latest advancements in translational proteomics and metabolomics. From uncovering the molecular mechanisms of disease pathology, to the latest technological developments in diagnostics and treatment.

In this webinar, we host two speakers who will present diverse case studies that will illustrate how multiomics is being used to deepen our understanding of human biology.

This presentation will highlight our recent progress in the discovery of N-glycans and phospholipids that significantly contribute to aberrant cancer metabolic pathways in primary tumors and metastases. We have also developed novel MALDI imaging approaches of drugs and drug metabolites that exploit key metabolic differences in tumors.

In this webinar you will learn how the power of large-scale proteomics can be leveraged for multiple divergent applications in the field of oncology.

In this webinar, our expert speaker, Professor Lei Liu, Assistant Professor of Neurology from Harvard Medical School will discuss strategies in developing an ultrasensitive immunoassay* to measure oligomeric amyloid β in human plasma precisely.

A microarray is a miniaturized assay comprising a solid surface printed with a multitude of molecules which are available for multiplex interaction and detection. They have applications in many fields including genomics, proteomics, diagnostics, biomarker quantitation and others.